Rachid Izzar - 30 Jun 2023 Form 4 Insider Report for BIOGEN INC. (BIIB)

Role
Head of Global Product Strat.
Signature
/s/ Wendell Taylor, attorney-in-fact for Rachid Izzar
Issuer symbol
BIIB
Transactions as of
30 Jun 2023
Transactions value $
-$69,503
Form type
4
Filing time
05 Jul 2023, 17:37:23 UTC
Previous filing
22 Feb 2023
Next filing
31 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIIB Common Stock Options Exercise $0 +504 +8.6% $0 6,388 30 Jun 2023 Direct
transaction BIIB Common Stock Tax liability -$69,503 -244 -3.8% $284.85 6,144 30 Jun 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIIB Restricted Stock Unit Options Exercise $0 -504 -100% $0* 0 30 Jun 2023 Common Stock 504 $0 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This award was granted to the reporting person on July 1, 2020, and vested in three equal installments on each anniversary of the grant date.